Hypertension induced by erythropoietin has a correlation with truncated erythropoietin receptor mRNA in endothelial progenitor cells of hemodialysis patients

Clinical Pharmacology and Therapeutics

Volumn 86, Issue 2, 2009, Pages 154-159

  Ioka, T ^a   Tsuruoka, S ^a,b   Ito, C ^a   Iwaguro, H ^c   Asahara, T ^c   Fujimura, A ^a   Kusano, E ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c TOKAI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; MESSENGER RNA; NITRIC OXIDE;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENETIC TRANSFECTION; HEMODIALYSIS; HUMAN; HUMAN CELL CULTURE; HYPERTENSION; IN VITRO STUDY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEM CELL;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; CELLS, CULTURED; CYCLIC GMP; DNA, COMPLEMENTARY; ENDOTHELIAL CELLS; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NITRIC OXIDE; POLYMERASE CHAIN REACTION; RECEPTORS, ERYTHROPOIETIN; RENAL DIALYSIS; RNA, MESSENGER; SIGNAL TRANSDUCTION; STEM CELLS; TRANSFECTION; UP-REGULATION;

EID: 67651146382     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2009.74     Document Type: Article

References (40)

1. Maschio, G. Erythropoietin and systemic hypertension. Nephrol. Dial. Transplant. 10 (suppl. 2),74-79 (1995).
2. Raine, A.E. Hypertension, blood viscosity, and cardiovascular morbidity in renal failure: implications of erythropoietin therapy. Lancet 1, 97-100 (1988).
3. Steffen, H.M. et al. Peripheral hemodynamics, blood viscosity, and the reninangiotensin system in hemodialysis patients under therapy with recombinant human erythropoietin. Contrib. Nephrol. 76, 292-298 (1989).
4. Neff, M.S., Kim, K.E., Persoff, M., Onesti, G. & Swartz, C. Hemodynamics of uremic anemia. Circulation 43, 876-883 (1971).
5. Vaziri, N.D. et al. Role of nitric oxide resistance in erythropoietin-induced hypertension in rats with chronic renal failure. Am. J. Physiol. 271, E113-E122 (1996).
6. Kaupke, C.J., Kim, S. & Vaziri, N.D. Effect of erythrocyte mass on arterial blood pressure in dialysis patients receiving maintenance erythropoietin therapy. J. Am. Soc. Nephrol. 4, 1874-1878 (1994).
7. Eggena, P. et al. Influence of recombinant human erythropoietin on blood pressure and tissue renin-angiotensin systems. Am. J. Physiol. 261, E642-E646 (1991).
8. Hand, M.F., Haynes, W.G., Johnstone, H.A., Anderton, J.L. & Webb, D.J. Erythropoietin enhances vascular responsiveness to norepinephrine in renal failure. Kidney Int. 48, 806-813 (1995).
9. Carlini, R.G., Dusso, A.S., Obialo, C.I., Alvarez, U.M. & Rothstein, M. Recombinant human erythropoietin (rHuEPO) increases endothelin-1 release by endothelial cells. Kidney Int. 43, 1010-1014 (1993).
10. Nagai, T. et al. Effects of rHuEpo on cellular proliferation and endothelin-1 production in cultured endothelial cells. Nephrol. Dial. Transplant. 10, 1814-1819 (1995).
11. Bode-Böger, S.M., Böger, R.H., Kuhn, M., Radermacher, J. & Frölich, J.C. Recombinant human erythropoietin enhances vasoconstrictor tone via endothelin-1 and constrictor prostanoids. Kidney Int. 50, 1255-1261 (1996).
12. Morakkabati, N., Gollnick, F., Meyer, R., Fandrey, J. & Jelkmann, W. Erythropoietin induces Ca2+ mobilization and contraction in rat mesangial and aortic smooth muscle cultures. Exp. Hematol. 24, 392-397 (1996).
13. Akimoto, T. et al. Erythropoietin modulates angiotensin II-or noradrenaline-induced Ca(2+) mobilization in cultured rat vascular smooth-muscle cells. Nephrol. Dial. Transplant. 16, 491-499 (2001).
14. Beleslin-Cokic, B.B., Cokic, V.P., Yu, X., Weksler, B.B., Schechter, A.N. & Noguchi, C.T. Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells. Blood 104, 2073-2080 (2004).
15. Banerjee, D., Rodriguez, M., Nag, M. & Adamson, J.W. Exposure of endothelial cells to recombinant human erythropoietin induces nitric oxide synthase activity. Kidney Int. 57, 1895-1904 (2000).
16. Scalera, F., Kielstein, J.T., Martens-Lobenhoffer, J., Postel, S.C., Täger, M. & Bode-Böger, S.M. Erythropoietin increases asymmetric dimethylarginine in endothelial cells: role of dimethylarginine dimethylaminohydrolase. J. Am. Soc. Nephrol. 16, 892-898 (2005).
17. Wang, X.Q. & Vaziri, N.D. Erythropoietin depresses nitric oxide synthase expression by human endothelial cells. Hypertension 33, 894-899 (1999).
18. Nakamura, Y., Komatsu, N. & Nakauchi, H. A truncated erythropoietin receptor that fails to prevent programmed cell death of erythroid cells. Science 257, 1138-1141 (1992).
19. Anagnostou, A., Lee, E.S., Kessimian, N., Levinson, R. & Steiner, M. Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc. Natl. Acad. Sci. USA 87, 5978-5982 (1990).
20. Chong, Z.Z. & Maiese, K. Erythropoietin involves the phosphatidylinositol 3-kinase pathway, 14-3-3 protein and FOXO3a nuclear traficking to preserve endothelial cell integrity. Br. J. Pharmacol. 150, 839-850 (2007).
21. Chong, Z.Z., Kang, J.Q. & Maiese, K. Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases. Circulation 106, 2973-2979 (2002).
22. Zhande, R. & Karsan, A. Erythropoietin promotes survival of primary human endothelial cells through PI3K-dependent, NF-kappaB-independent upregulation of Bcl-xL. Am. J. Physiol. Heart Circ. Physiol. 292, H2467-H2474 (2007).
23. Asahara, T. et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 964-967 (1997).
24. Werner, N. et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N. Engl. J. Med. 353, 999-1007 (2005).
25. Hill, J.M. et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 348, 593-600 (2003).
26. Effect of recombinant human erythropoietin therapy on blood pressure in hemodialysis patients. Canadian Erythropoietin Study Group. Am. J. Nephrol. 11, 23-26 (1991).
27. Caravaca, F., Pizarro, J.L., Arrobas, M., Cubero, J.J., Garcia, M.C. & Perez-Miranda, M. Antiplatelet therapy and development of hypertension induced by recombinant human erythropoietin in uremic patients. Kidney Int. 45, 845-851 (1994).
28. Ishimitsu, T., Tsukada, H., Ogawa, Y., Numabe, A. & Yagi, S. Genetic predisposition to hypertension facilitates blood pressure elevation in hemodialysis patients treated with erythropoietin. Am. J. Med. 94, 401-406 (1993).
29. Santhanam, A.V., Smith, L.A., Akiyama, M., Rosales, A.G., Bailey, K.R. & Katusic, Z.S. Role of endothelial NO synthase phosphorylation in cerebrovascular protective effect of recombinant erythropoietin during subarachnoid hemorrhage-induced cerebral vasospasm. Stroke 36, 2731-2737 (2005).
30. Lee, S.T. et al. Erythropoietin reduces perihematomal inflammation and cell death with eNOS and STAT3 activations in experimental intracerebral hemorrhage. J. Neurochem. 96, 1728-1739 (2006).
31. Urao, N. et al. Erythropoietin-mobilized endothelial progenitors enhance reendothelialization via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia. Circ. Res. 98, 1405-1413 (2006).
32. Fulton, D. et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399, 597-601 (1999).
33. Dimmeler, S., Fleming, I., Fisslthaler, B., Hermann, C., Busse, R. & Zeiher, A.M. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399, 601-605 (1999).
34. Bogoyevitch, M.A. An update on the cardiac effects of erythropoietin cardioprotection by erythropoietin and the lessons learnt from studies in neuroprotection. Cardiovasc. Res. 63, 208-216 (2004).
35. Fisher, J.W. Erythropoietin: physiology and pharmacology update. Exp. Biol. Med. (Maywood) 228, 1-14 (2003).
36. Brines, M. et al. Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc. Natl. Acad. Sci. USA 101, 14907-14912 (2004).
37. Iwaguro, H. & Asahara, T. Endothelial progenitor cell culture and gene transfer. Methods Mol. Med. 112, 239-247 (2005).
38. Eizawa, T. et al. Circulating endothelial progenitor cells are reduced in hemodialysis patients. Curr. Med. Res. Opin. 19, 627-633 (2003).
39. Yamamoto, H. et al. Indoxyl sulfate stimulates proliferation of rat vascular smooth muscle cells. Kidney Int. 69, 1780-1785 (2006).
40. Kotnis, R.A., Thompson, M.M., Eady, S.L., Budd, J.S., Bell, P.R. & James, R.F. Optimisation of gene transfer into vascular endothelial cells using electroporation. Eur. J. Vasc. Endovasc. Surg. 9, 71-79 (1995).